DiObex: Clinical Trials

4 trials sponsored by DiObex, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated. 3 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 2, Completed 1
Phase 12Completed 2
Phase 31Terminated 1

Follow DiObex: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients
DIO-902 - Type 2 Diabetes
Phase 2 / Phase 3TerminatedDiObex1502008-01-012008-05-28
A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes
DIO-902, DIO-902 placebo - Type 2 Diabetes
Phase 2TerminatedDiObex2002007-07-012008-11-13
A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Very Low Dose-Glucagon in Subjects With Type 1 Diabetes Mellitus
very low dose (VLD) glucagon - Type 1 Diabetes
Phase 1CompletedDiObex102006-03-012006-08-23
A Phase 1/2a Study of the 2S,4R Enantiomer of Ketoconazole in Subjects With Type 2 Diabetes Mellitus
2S, 4R Ketoconazole (DIO-902) - Type 2 Diabetes
Phase 1 / Phase 2CompletedDiObex502005-02-012008-02-22

Conditions studied

Diabetes Mellitus (3)  ·  Diabetes Mellitus, Type 2 (3)  ·  Diabetes Mellitus, Type 1 (1)

Interventions

Glucagon (1)

Countries

United States (4)  ·  Australia (2)  ·  New Zealand (2)

Top investigators

Sherwin Schwartz, MD (1)  ·  Sherwyn Schwartz, MD (1)  ·  Steven Edelman, MD (1)